Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.
Davis JM 3rd, Knutson KL, Skinner JA, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE.
Arthritis Res Ther. 2012 Jan 31;14(1):R24. [Epub ahead of print]
Related citations
Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis.
Makrygiannakis D, Revu S, Engström M, Af Klint E, Nicholas AP, Pruijn GJ, Catrina AI.
Arthritis Res Ther. 2012 Jan 27;14(1):R20. [Epub ahead of print]
Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.
Hwang SJ, Choi B, Kang SS, Chang JH, Kim YG, Chung YH, Sohn DH, So MW, Lee CK, Robinson WH, Chang EJ.
Arthritis Res Ther. 2012 Jan 20;14(1):R14. [Epub ahead of print]
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.
Fleishaker DL, Garcia Meijide JA, Petrov A, Kohen MD, Wang X, Menon S, Stock TC, Mebus CA, Goodrich JM, Mayer HB, Zeiher BG.
Arthritis Res Ther. 2012 Jan 17;14(1):R11. [Epub ahead of print]
Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry.
Fueldner C, Mittag A, Knauer J, Biskop M, Hepp P, Scholz R, Wagner U, Sack U, Emmrich F, Tárnok A, Lehmann J.
Arthritis Res Ther. 2012 Jan 17;14(1):R8. [Epub ahead of print]
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.
Yukawa N, Fujii T, Kondo-Ishikawa S, Yoshifuji H, Kawabata D, Nojima T, Ohmura K, Usui T, Mimori T.
Arthritis Res Ther. 2011;13(6):R213. Epub 2011 Dec 22.
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.
Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.
Arthritis Res Ther. 2011;13(6):R209. Epub 2011 Dec 16.
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects.
Eggleton P, Bremer E, Tarr JM, de Bruyn M, Helfrich W, Kendall A, Haigh RC, Viner NJ, Winyard PG.
Arthritis Res Ther. 2011;13(6):R208. Epub 2011 Dec 15.
Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.
Guyot P, Taylor P, Christensen R, Pericleous L, Poncet C, Lebmeier M, Drost P, Bergman G.
Arthritis Res Ther. 2011;13(6):R204. Epub 2011 Dec 12.
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, Borea PA.
Arthritis Res Ther. 2011;13(6):R197. Epub 2011 Dec 6.
Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
Shoda H, Fujio K, Shibuya M, Okamura T, Sumitomo S, Okamoto A, Sawada T, Yamamoto K.
Arthritis Res Ther. 2011;13(6):R191. Epub 2011 Nov 22.
Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement.
Garneau KL, Iversen MD, Tsao H, Solomon DH.
Arthritis Res Ther. 2011;13(6):R189. Epub 2011 Nov 18.
Integrins and their ligands in rheumatoid arthritis.
Lowin T, Straub RH.
Arthritis Res Ther. 2011;13(5):244. Epub 2011 Oct 28.
The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
Hammer HB, Fagerhol MK, Wien TN, Kvien TK.
Arthritis Res Ther. 2011;13(5):R178. Epub 2011 Oct 26.
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.
Scheerens H, Su Z, Irving B, Townsend MJ, Zheng Y, Stefanich E, Chindalore V, Bingham CO 3rd, Davis JC Jr.
Arthritis Res Ther. 2011;13(5):R177. Epub 2011 Oct 26.
Declining needs for total joint replacements for rheumatoid arthritis.
Khan NA, Sokka T.
Arthritis Res Ther. 2011;13(5):130. Epub 2011 Oct 19.
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.
Smith CJ, Sayles H, Mikuls TR, Michaud K.
Arthritis Res Ther. 2011;13(5):R168. Epub 2011 Oct 18.
Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments.
Kim SY, Solomon DH.
Arthritis Res Ther. 2011;13(5):129. Epub 2011 Oct 7.
HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients.
Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H, Tikly M, Anderson R.
Arthritis Res Ther. 2011;13(5):R160. Epub 2011 Oct 6.
Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kaneko K, Miyabe Y, Takayasu A, Fukuda S, Miyabe C, Ebisawa M, Yokoyama W, Watanabe K, Imai T, Muramoto K, Terashima Y, Sugihara T, Matsushima K, Miyasaka N, Nanki T.
Arthritis Res Ther. 2011;13(5):R158. Epub 2011 Sep 29.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on